These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35250293)

  • 1. TLR3 Expression is a Potential Prognosis Biomarker and Shapes the Immune-Active Tumor Microenvironment in Esophageal Squamous Cell Carcinoma.
    Su R; Cai L; Xiong P; Liu Z; Chen S; Liu X; Lin R; Lei Z; Tian D; Su M
    J Inflamm Res; 2022; 15():1437-1456. PubMed ID: 35250293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
    Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y
    Front Oncol; 2021; 11():769727. PubMed ID: 34926275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of TLR3 in triple-negative breast cancer predicts better prognosis-data from the Fudan University Shanghai Cancer Center cohort and tissue microarrays.
    Fan L; Sui XY; Jin X; Zhang WJ; Zhou P; Shao ZM
    BMC Cancer; 2023 Apr; 23(1):298. PubMed ID: 37005579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative analysis of tertiary lymphoid structures and immune microenvironment in patients with esophageal carcinoma.
    Yao Y; Xuan H; Wang J; Gong L; Gao W
    Tumori; 2023 Oct; 109(5):466-480. PubMed ID: 37249074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of miR-145-5p in esophageal squamous cell carcinoma tumor-associated macrophages and selection of immunochemotherapy.
    Lin J; Wu S; Zhu K; Zhang J; Shi X; Shen J; Xu J
    J Thorac Dis; 2022 Jul; 14(7):2493-2510. PubMed ID: 35928615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
    Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
    Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR3 expression status predicts prognosis in patients with advanced thoracic esophageal squamous cell carcinoma after esophagectomy.
    Sato Y; Motoyama S; Wakita A; Kawakita Y; Liu J; Nagaki Y; Nanjo H; Terata K; Imai K; Saito H; Minamiya Y
    Am J Surg; 2018 Aug; 216(2):319-325. PubMed ID: 29395019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic profiling and prognostic significance of immune infiltrates in esophageal squamous cell carcinoma.
    Pan C; Wang Y; Liu Q; Hu Y; Fu J; Xie X; Zhang S; Xi M; Wen J
    Oncoimmunology; 2021 Feb; 10(1):1883890. PubMed ID: 33628625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MXD1 is a Potential Prognostic Biomarker and Correlated With Specific Molecular Change and Tumor Microenvironment Feature in Esophageal Squamous Cell Carcinoma.
    Du F; Dong D; Zhang X; Jia J
    Technol Cancer Res Treat; 2021; 20():15330338211052142. PubMed ID: 34761715
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma.
    Liu X; Zhang M; Ying S; Zhang C; Lin R; Zheng J; Zhang G; Tian D; Guo Y; Du C; Chen Y; Chen S; Su X; Ji J; Deng W; Li X; Qiu S; Yan R; Xu Z; Wang Y; Guo Y; Cui J; Zhuang S; Yu H; Zheng Q; Marom M; Sheng S; Zhang G; Hu S; Li R; Su M
    Gastroenterology; 2017 Jul; 153(1):166-177. PubMed ID: 28365443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma.
    Chen K; Zhu Z; Zhang N; Cheng G; Zhang F; Jin J; Wu J; Ying L; Mao W; Su D
    Med Sci Monit; 2017 Sep; 23():4619-4632. PubMed ID: 28949934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-1H Expression Associated With CD68 Macrophage Marker Confers an Immune-Activated Microenvironment and Favorable Overall Survival in Human Esophageal Squamous Cell Carcinoma.
    Chen Y; Feng R; He B; Wang J; Xian N; Huang G; Zhang Q
    Front Mol Biosci; 2021; 8():777370. PubMed ID: 34950702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel immune-related gene signature predicts survival in esophageal squamous cell carcinoma.
    Xu T; Dai T; Zeng P; Guo Y; He K
    Transl Cancer Res; 2021 May; 10(5):2354-2367. PubMed ID: 35116551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma.
    Sheyhidin I; Nabi G; Hasim A; Zhang RP; Ainiwaer J; Ma H; Wang H
    World J Gastroenterol; 2011 Aug; 17(32):3745-51. PubMed ID: 21990957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
    Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
    Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ORAOV1 overexpression in esophageal squamous cell carcinoma and esophageal dysplasia: a possible biomarker of progression and poor prognosis in esophageal carcinoma.
    Li M; Cui X; Shen Y; Dong H; Liang W; Chen Y; Hu J; Li S; Kong J; Li H; Zhao J; Li F
    Hum Pathol; 2015 May; 46(5):707-15. PubMed ID: 25732110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of prognostic genes and tumor-infiltrating immune cells in the tumor microenvironment of esophageal squamous cell carcinoma and esophageal adenocarcinoma.
    Huai Q; Guo W; Han L; Kong D; Zhao L; Song P; Peng Y; Gao S
    Transl Cancer Res; 2021 Apr; 10(4):1787-1803. PubMed ID: 35116502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Tumor Antigens and Immune Subtypes of Esophageal Squamous Cell Carcinoma for mRNA Vaccine Development.
    Lu T; Xu R; Wang CH; Zhao JY; Peng B; Wang J; Zhang LY
    Front Genet; 2022; 13():853113. PubMed ID: 35734437
    [No Abstract]   [Full Text] [Related]  

  • 20. Untargeted metabolomics analysis of esophageal squamous cell cancer progression.
    Yang T; Hui R; Nouws J; Sauler M; Zeng T; Wu Q
    J Transl Med; 2022 Mar; 20(1):127. PubMed ID: 35287685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.